GRAIL, Inc. (GRAL) stock
Close on Nov 12, 2026Market cap $5.42BP/E –Yield –
GRAIL, Inc. grew revenue 17.5% to $166.60M over the twelve months to Sep 30, 2026. Free cash flow was -$312.00M. At the latest close the market valued the company at $5.42B.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $5.42B
- P/E ratio
- –
- Price to sales
- 32.53
- Price to book
- 2.21
- Dividend yield
- –
- Free cash flow yield
- -5.76%
Fundamentals
- Revenue
- $166.60M
- Net income
- -$406.18M
- EPS, diluted
- -$9.49
- Free cash flow
- -$312.00M
- Book value per share
- $52.45
- Diluted shares
- 47M
Trading
- Next earnings
- Feb 18, 2027 (estimated, after the close)
- Previous close
- $125.64
- Open
- $120.50
- Day's range
- $115.28 – $122.68
- Volume
- 596,903
- Average volume (20 days)
- 936,289
- Index membership
- Russell 2000 (since Jun 2025), Russell 3000 (since Aug 2024)
- Beta (5 years)
- 2.52
- 52-week range
- $41.50 – $166.47
- RSI (14 days)
- 45.1
- Volatility (1 year)
- 102.5%
- Relative volume
- 0.64×
- WACC
- 17.4%
On 1 of our idea list: Most shorted (a warning list)
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2024, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.
| Period | GRAL | S&P 500 | Difference | GRAL per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -11.7% | -2.7% | −9.0 pts | ||
| 3 months | +76.0% | -1.7% | +77.8 pts | ||
| Year to date | +41.8% | +11.9% | +29.9 pts | ||
| 1 year | +43.2% | +12.0% | +31.2 pts |
Five years at a glance
Fiscal years 2021 to 2025 and trailing twelve months, USD
Revenue
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Grail filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- News
- Results
- Results
- Results
About Grail
Services-Medical Laboratories
The company is a commercial-stage healthcare organization focused on multi-cancer early detection at population scale. Its core offering is Galleri, a multi-cancer early detection screening blood test designed to screen for over 50 cancer types by analyzing cell-free DNA methylation patterns and predicting the cancer signal of origin. Beyond asymptomatic population screening, the business offers a research-use-only targeted methylation platform with customizable classifiers for biopharmaceutical and oncology therapeutics partners, supporting precision oncology applications such as biomarker discovery, prognosis, and recurrence monitoring. Its customer base includes healthcare systems, self-insured employers, digital health platforms, health insurers, life insurance providers, and biopharmaceutical developers.
Company profile, executives and historyGrail stock: common questions
What is Grail's stock price?
GRAL closed at $121.35 on Nov 12, 2026, down 3.41% on the day. Over the past 52 weeks it traded between $41.50 and $166.47.
What is Grail's market cap?
Grail was worth $5.42B at the close on Nov 12, 2026: the share price times the diluted shares outstanding.
What is GRAL's P/E ratio?
Grail lost money over the twelve months to Sep 30, 2026 (diluted EPS -$9.49), so it has no meaningful P/E ratio.
How much revenue does Grail make?
Grail reported revenue of $166.60M for the twelve months to Sep 30, 2026, up 17.5% from a year earlier.
Does Grail pay a dividend?
No. Grail has not paid a cash dividend over the last twelve months.
When does Grail report earnings next?
Grail is expected to report Q4 FY2026 results on Feb 18, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has GRAL stock performed over the past year?
Including dividends, GRAL returned +43.2% over the past year, against +12.0% for the S&P 500.
How many GRAL shares are sold short?
8M shares were sold short at the latest FINRA report, 20.12% of the float, or 8.7 days of average trading volume.
Who are Grail's competitors?
Companies most similar to Grail by business, industry and size include PSNL, BLLN, GH, MDXH, FLGT.
See a number that looks wrong?